Skip to content
Pharma Observatory a Scientist.com platform

Organization (Hospital)

Hospital Universitari Son Dureta

ClinicalTrials.gov lists Hospital Universitari Son Dureta as lead sponsor of 10 trials. It has 5 approved assets.

ES Hospital
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

3 0 2002 2026

Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

2026 is partial: 0 registered with a 2026 start date. The dashed outline is the pace from the 0 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.

This page covers Hospital Universitari Son Dureta: 10 lead-sponsored trials and 0 legal-entity registrations.

Get the Hospital Universitari Son Dureta report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Disease areas (11)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Pulmonary Disease, Chronic Obstructive 5
Emphysema 2
HIV Infections 2
Inflammation 2
Acute Lung Injury 1

Trials by start year as sponsor or collaborator (7)

Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Show the table of trials by start year as sponsor or collaborator
Trials by start year as sponsor or collaborator
Year Trials started
2010 3
2009 2
2008 1
2007 2
2005 2
2004 1
2002 1

Recruitment duration, a model prediction: none of the 10 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

Approved assets (5)

Shown in this order: max phase first.

Approved assets
Drug Trials
SIMVASTATIN 1
Pentobarbital 1
Thiopental 1
Glutamine 1
Theophylline 1

Journals published in (25)

Shown in this order: most published in first.

Journals published in
Journal Publications
Critical care medicine 5
American journal of respiratory and critical care medicine 3
Critical care (London, England) 3
AIDS (London, England) 1
American journal of physiology. Lung cellular and molecular physiology 1

Organization relationships (7)

Shown in this order: most evidence first.

Organization relationships
Related organization Relationship Evidence
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau Co sponsors trial with 1
Cimera Co sponsors trial with 1
Germans Trias i Pujol Hospital Co sponsors trial with 1
Hospital Universitario Reina Sofia de Cordoba Co sponsors trial with 1
Hospital Miguel Servet Co sponsors trial with 1

Latest dated events (12)

Shown in this order: newest first.

Latest dated events
Date Event Source
2010-10 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2010-10 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2010-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2009-08 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2009-05 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))

Biomarker capability evidence (6)

Shown in this order: tier desc, then gene symbol.

Biomarker capability evidence
Gene Role Evidence
BCLAF1 Trial sponsor Named in trial inclusion criteria
CD4 Trial sponsor Named in trial inclusion criteria
PTH Trial sponsor Named in trial exclusion criteria
BCLAF1 Trial sponsor Mentioned in trial text
CD4 Trial sponsor Mentioned in trial text

Biomarkers this organization publishes on (7)

Shown in this order: most publications first.

Biomarkers this organization publishes on
Biomarker Publications
BCL2 1
BTK 1
CXCL8 1
IL6 1
KRT20 1

Not on this page

Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, active development programs, sponsor delivery record, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, and clia clinical laboratory certificates.